EAM Investors’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-92,522
| Closed | -$499K | – | 256 |
|
|
2024
Q3 | $499K | Buy |
+92,522
| New | +$499K | 0.07% | 231 |
|
|
2023
Q2 | – | Sell |
-211,388
| Closed | -$2.1M | – | 260 |
|
|
2023
Q1 | $2.1M | Buy |
211,388
+13,160
| +7% | +$131K | 0.41% | 94 |
|
|
2022
Q4 | $1.38M | Sell |
198,228
-35,410
| -15% | -$246K | 0.29% | 160 |
|
|
2022
Q3 | $1.25M | Buy |
+233,638
| New | +$1.25M | 0.27% | 162 |
|
|
2021
Q3 | – | Sell |
-328,539
| Closed | -$3.72M | – | 281 |
|
|
2021
Q2 | $3.72M | Buy |
328,539
+225,348
| +218% | +$2.55M | 0.57% | 33 |
|
|
2021
Q1 | $1.23M | Buy |
+103,191
| New | +$1.23M | 0.18% | 269 |
|
|
2019
Q1 | – | Sell |
-310,024
| Closed | -$2.57M | – | 251 |
|
|
2018
Q4 | $2.57M | Sell |
310,024
-2,068
| -0.7% | -$17.2K | 0.7% | 27 |
|
|
2018
Q3 | $4.31M | Buy |
+312,092
| New | +$4.31M | 0.64% | 25 |
|